Federal Register / Vol. 80, No. 26 / Monday, February 9, 2015 / Notices 6971 

Dated: February 3, 2015. 

Edward Loeb, 

Acting Director, Office of Government-wide 

Acquisition Policy, Office of Acquisition 

Policy, Office of Government-wide Policy. 

[FR Doc. 2015–02546 Filed 2–6–15; 8:45 am] 

BILLING CODE 6820–EP–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substances and 

Disease Registry 

Availability of Final Toxicological 

Profiles 

AGENCY: Agency for Toxic Substances 

and Disease Registry (ATSDR), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of availability. 

SUMMARY: This notice announces the 

availability of the final Toxicological 

Profiles Toxaphene and 

Trichlorobenzenes prepared by ATSDR. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Delores Grant, Division of Toxicology 

and Human Health Sciences, Agency for 

Toxic Substances and Disease Registry, 

Mailstop F–57, 1600 Clifton Road, NE., 

Atlanta, Georgia 30333; telephone 

number (800) 232–4636 or (770)488– 

3351. Electronic access to these 

documents is available at the ATSDR 

Web site: www.atsdr.cdc.gov/

toxprofiles/index.asp. 

SUPPLEMENTARY INFORMATION: The 

Superfund Amendments and 

Reauthorization Act of 1986 (SARA) (42 

U.S.C. 9601 et seq.) amended the 

Comprehensive Environmental 

Response, Compensation, and Liability 

Act of 1980 (CERCLA or Superfund) (42 

U.S.C. 9601 et seq.) by establishing 

certain requirements for ATSDR and the 

U.S. Environmental Protection Agency 

(EPA) with regard to hazardous 

substances that are most commonly 

found at facilities on the CERCLA 

National Priorities List (NPL). Among 

these statutory requirements is a 

mandate for the Administrator of 

ATSDR to prepare toxicological profiles 

for each substance included on the 

priority list of hazardous substances 

(also called the Substance Priority List). 

This list identifies 275 hazardous 

substances that ATSDR (in cooperation 

with EPA) has determined pose the 

most significant potential threat to 

human health. The availability of the 

revised list of the 275 priority 

substances was announced in the 

Federal Register on May 28, 2014 (79 

FR 30613) and is available at 

www.atsdr.cdc.gov/spl. In addition, 

ATSDR has the authority to prepare 

toxicological profiles for substances not 

found at sites on the National Priorities 

List, in an effort to ‘‘. . . establish and 

maintain inventory of literature, 

research, and studies on the health 

effects of toxic substances’’ under 

CERCLA Section 104(i)(1)(B), to respond 

to requests for consultation under 

section 104(i)(4), and as otherwise 

necessary to support the site-specific 

response actions conducted by ATSDR. 

Notice of the availability of these 

toxicological profiles in draft form for 

public review and comment was 

published in the Federal Register on 

November 22, 2010 (75 FR 71132), with 

notice of a 90-day public comment 

period, starting from the actual release 

date. Following the close of the 

comment period, chemical-specific 

comments were addressed, and, where 

appropriate, changes were incorporated 

into the profile. This material is 

available for public inspection at 

ATSDR. 

Availability 

This notice announces the availability 

of the Toxicological Profiles for 

Toxaphene and Trichlorobenzenes 

prepared by ATSDR. The Toxicological 

Profiles for these substances will be 

made available to the public on or about 

October 17, 2015 at the ATSDR Web 

site: www.atsdr.cdc.gov/toxprofiles/

index.asp. 

These final profiles are also available 

through the U.S. Department of 

Commerce, National Technical 

Information Service (NTIS), 5285 Port 

Royal Road, Springfield, Virginia 22161, 

telephone 1–800–553–6847 for a fee as 

determined by NTIS. 

Dated: February 3, 2015. 

Sascha Chaney, 

Acting Director, Office of Policy, Planning 

and Evaluation, National Center for 

Environmental Health, Agency for Toxic 

Substances and Disease Registry. 

[FR Doc. 2015–02544 Filed 2–6–15; 8:45 am] 

BILLING CODE 4163–70–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Health Statistics: 

Notice of Charter Renewal 

This gives notice under the Federal 

Advisory Committee Act (Pub. L. 92– 

463) of October 6, 1972, that the Board 

of Scientific Counselors, National 

Center for Health Statistics, Department 

of Health and Human Services, has been 

renewed for a 2-year period through 

January 19, 2017. 

For information, contact Virginia 

Cain, Ph.D., Designated Federal Officer, 

Board of Scientific Counselors, National 

Center for Health Statistics, Department 

of Health and Human Services, 3311 

Toledo Road, Room 7204, Mailstop P08, 

Hyattsville, Maryland 20782, telephone 

301/458–4395 or fax 301/458–4020. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–02451 Filed 2–6–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns ‘‘Comprehensive High-Impact 

HIV Prevention Projects for CommunityBased Organizations’’, Funding 

Opportunity Announcement (FOA) 

PS15–1502, initial review. 

In accordance with Section 10(a) (2) 

of the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 9:00 a.m.–4:00 p.m., EST, 

Panels 1–5; March 3, 2015 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters for Discussion: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Comprehensive High-Impact 

HIV Prevention Projects for CommunityBased Organizations’’ FOA PS15–1502. The 

panel is reconvening to review 44 additional 

applications that have been deemed eligible 

for FOA PS15–1502. 

Contact Person for More Information: 

Elizabeth Wolfe, Public Health Advisor, CDC, 

1600 Clifton Road, NE., Mailstop E07, 

mstockstill on DSK4VPTVN1PROD with NOTICES

6972 Federal Register / Vol. 80, No. 26 / Monday, February 9, 2015 / Notices 

Atlanta, Georgia 30333, Telephone: (404) 

639–8135. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–02450 Filed 2–6–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Comment Request 

Proposed Projects 

Title: ORR Requirements for Refugee 

Cash Assistance; and Refugee Medical 

Assistance (45 CFR part 400). 

OMB No.: 0970–0036. 

Description: As required by section 

412(e) of the Immigration and 

Nationality Act, the Administration for 

Children and Families (ACF), Office of 

Refugee Resettlement (ORR), is 

requesting the information from Form 

ORR–6 to determine the effectiveness of 

the State cash and medical assistance, 

social services, and targeted assistance 

programs. State-by-State Refugee Cash 

Assistance (RCA) and Refugee Medical 

Assistance (RMA) utilization rates 

derived from Form ORR–6 are 

calculated for use in formulating 

program initiatives, priorities, 

standards, budget requests, and 

assistance policies. ORR regulations 

require that State Refugee Resettlement 

and Wilson-Fish agencies, and local and 

Tribal governments complete Form 

ORR–6 in order to participate in the 

above-mentioned programs. 

Respondents: State Refugee 

Resettlement and Wilson-Fish Agencies, 

local, and Tribal governments. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average burden 

hours per 

response 

Total burden 

hours 

ORR–6 ............................................................................................. 50 3 3.88 582 

Estimated Total Annual Burden 

Hours: 582. 

In compliance with the requirements 

of Section 506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 

to the Administration for Children and 

Families, Office of Planning, Research 

and Evaluation, 370 L’Enfant 

Promenade SW., Washington, DC 20447, 

Attn: ACF Reports Clearance Officer. 

Email address: infocollection@

acf.hhs.gov. All requests should be 

identified by the title of the information 

collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden 

information to be collected; and (e) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2015–02510 Filed 2–6–15; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2015–N–0126] 

Authorizations of Emergency Use of In 

Vitro Diagnostic Devices for Detection 

of Ebola Virus; Availability 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

issuance of three Emergency Use 

Authorizations (EUAs) (the 

Authorizations), one of which was 

amended after initial issuance, for three 

in vitro diagnostic devices for detection 

of the Ebola virus in response to the 

2014 Ebola virus outbreak in West 

Africa. FDA is issuing these 

Authorizations under the Federal Food, 

Drug, and Cosmetic Act (the FD&C Act), 

as requested by BioFire Defense, LLC 

(BioFire Defense) and altona Diagnostics 

GmbH (altona). The Authorizations 

contain, among other things, conditions 

on the emergency use of the authorized 

in vitro diagnostic devices. The 

Authorizations follow the September 22, 

2006, determination by then-Secretary 

of the Department of Homeland Security 

(DHS), Michael Chertoff, that the Ebola 

virus presents a material threat against 

the U.S. population sufficient to affect 

national security. On the basis of such 

determination, the Secretary of Health 

and Human Services (HHS) declared on 

August 5, 2014, that circumstances exist 

justifying the authorization of 

emergency use of in vitro diagnostics for 

detection of Ebola virus subject to the 

terms of any authorization issued under 

the FD&C Act. The Authorizations, 

which include an explanation of the 

reasons for issuance, are reprinted in 

this document. 

DATES: The Authorizations for the 

BioFire FilmArray NGDS BT–E Assay 

and BioFire FilmArray Biothreat-E test 

are effective as of October 25, 2014. The 

Authorization for the altona RealStar®

Ebolavirus RT–PCR Kit 1.0, which was 

amended and reissued on November 26, 

2014, is effective as of November 10, 

2014. 

ADDRESSES: Submit written requests for 

single copies of the EUAs to the Office 

of Counterterrorism and Emerging 

Threats, Food and Drug Administration, 

10903 New Hampshire Ave., Bldg. 1, 

Rm. 4338, Silver Spring, MD 20993– 

0002. Send one self-addressed adhesive 

label to assist that office in processing 

your request or include a fax number to 

which the Authorizations may be sent. 

See the SUPPLEMENTARY INFORMATION

mstockstill on DSK4VPTVN1PROD with NOTICES